Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

November 11, 2019
Three Steps Towards Fulfilling the EMA Nitrosamine Advice
How a results-driven, chemistry-based strategy will enable companies to meet MAH responsibilities with the… Read More
November 7, 2019
Meet the Expert: Hannah Hunter
Hear from Hannah Hunter, Associate Director of MI Operations based in our Richmond, North… Read More
October 16, 2019
Meet the Expert: Xenia Freifrau von Maltzan
Hear from our Berlin colleague, Xenia von Maltzan, on her perspective of the medical… Read More
More Articles

UPCOMING Events

November 20, 2019
DIA European Medical Information and Communications Conference
This unique meeting is organised by medical information professionals for medical information professionals. T... Read More
December 04, 2019
Cannabiz Innovation Hub
Join us for a unique platform to debate best practices that are imperative to enabling scale, efficiency and i... Read More
All Events
Contact Us